Key Highlights
- Shares of Meta rallied approximately 7% following the surprise debut of Muse Spark AI
- The new model includes multimodal reasoning capabilities, tool integration, and multi-agent coordination
- Leading analysts from Mizuho, William Blair, and Bank of America reaffirmed positive ratings
- Wall Street’s consensus target price stands at $862.05, suggesting potential gains of ~41%
- The company overhauled its pretraining infrastructure, achieving comparable performance with significantly reduced computational resources
Meta Platforms delivered an unexpected announcement on Wednesday, launching Muse Spark ahead of schedule—the inaugural AI model from its newly established Meta Superintelligence Labs. Shares finished the trading session up approximately 7%, reaching $612.42.
The timing of this release, coming just weeks ahead of Meta’s scheduled April 29 earnings report, provides market participants with tangible developments to evaluate before quarterly results arrive.
As the debut offering in Meta’s Muse lineup, Muse Spark delivers native multimodal reasoning functionality, tool integration capabilities, visual chain-of-thought processing, and multi-agent coordination features. Users can access the model through meta.ai and the Meta AI application, while a limited API preview has been made available to selected participants.
Additionally, Meta unveiled Contemplating mode, an innovative feature enabling simultaneous reasoning across multiple agents. The system achieved a 58% score on Humanity’s Last Exam and recorded 38% on FrontierScience Research benchmarks.
The technology giant invested nine months reconstructing its pretraining infrastructure, enhancing model design, optimization techniques, and data refinement processes. According to Meta, these improvements enabled the achievement of similar performance levels while utilizing more than ten times less computational power compared to Llama 4 Maverick, its predecessor.
Muse Spark incorporates specialized health-oriented features as well. The company collaborated with over 1,000 medical professionals to develop training datasets for health-related inquiries. Users can generate interactive visualizations displaying information such as nutritional breakdowns and muscle engagement during physical activities.
Regarding safety protocols, Meta conducted comprehensive testing under its Advanced AI Scaling Framework. Results demonstrated robust refusal mechanisms across high-risk categories, including biological and chemical weaponry. Independent evaluator Apollo Research identified it as exhibiting the strongest evaluation awareness among all models in their testing portfolio.
Wall Street Analysts Endorse the Launch
Mizuho analyst Lloyd Walmsley maintained his Outperform stance with an $850 price objective. He characterized the accelerated launch as evidence of substantial AI advancement and highlighted shopping and search functionalities as promising revenue opportunities. Walmsley acknowledged that investors remain eager for greater clarity on how Meta will translate AI investments into measurable financial returns.
William Blair’s Ralph Schackart retained his Outperform recommendation, suggesting the launch could alleviate persistent questions about Meta’s AI development trajectory. He indicated that subsequent model iterations will prove crucial in assessing returns on AI capital expenditures. Schackart identified significant potential in business AI applications and commerce tools.
Bank of America’s Justin Post reaffirmed his Buy rating alongside an $885 price objective. He stated the earlier-than-expected release diminishes uncertainty surrounding Meta’s AI strategy. Drawing comparisons to Alphabet, Post observed that consistent AI advancement typically boosts investor confidence progressively. He also characterized Meta’s current valuation as attractive given the robustness of its advertising operations.
Street Sentiment Overview
With 39 Buy recommendations, six Hold positions, and zero Sell ratings recorded over the latest three-month period, Meta commands a Strong Buy consensus among Wall Street analysts.
The consensus price objective sits at $862.05, indicating approximately 41% potential appreciation from Wednesday’s closing price.



